| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 宁波美康生物科技股份有限公司是一家专业从事生物科技新产品的研发、生产、销售及服务的高科技企业.企业位于浙江省宁波市,拥有省级企业工程(技术)中心;企业通过ISO9001:2008及ISO13485:2003国际质量管理体系双认证;2006年被评为"全国第三届卫生产业企业先进单位",2008年被评为国家级"高新技术企业",2011年被评为"国家火炬计划重点高新技术企业".公司目前已经取得87个产品的注册证,是国内医疗试剂行业品种最全的厂家之一;公司研发的"胆红素化学氧化法检测"填补了国内该项产品的空白;"糖化血红蛋白酶法检测试剂盒"为国内首创,并列入"2010年科技部国家创新基金项目"、"2011年国家重点新产品计划项目";糖化白蛋白(GA)、缺血修饰白蛋白(IMA)、胱抑素C、D-二聚体(D-dimer)等均为我公司重点推荐产品。 | ||||||||||||||||||||||||
| Main Business | 体外诊断产品的研发、生产和销售及体外诊断产品的代理业务，并提供第三方医学诊断服务。 | ||||||||||||||||||||||||
| Legal Representative | 邹炳德 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 熊慧萍 | ||||||||||||||||||||||||
| Solicitors | 国浩律师（杭州）事务所 | ||||||||||||||||||||||||
| Auditors | 立信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0574-88178818 | ||||||||||||||||||||||||
| Fax No | 0574-88178518 | ||||||||||||||||||||||||
| Website | www.nbmksw.com | ||||||||||||||||||||||||
| mksw@nbmksw.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 22/04/2015 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.670 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.134 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 7.089 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.136B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |